Global Computer-Assisted Coding Market, By Application

According to the new market research report "Computer Assisted Coding Market by Software (Natural Language Processing, Structured Input, Integrated Systems), Service (Support, Education & Training), Application (Automated Encoding, Clinical Coding Audit, Management Reporting) - Global Forecast to 2022", published by MarketsandMarkets™, The global computer-assisted coding market is valued at USD 2.76 Billion in 2017 and is expected to register a CAGR of 11.5% to reach to USD 4.75 Billion by 2022.


The growth of the market can be attributed to factors such as the growing adoption of CAC solutions in North America due to the implementation of International Classification of Diseases (ICD)-10 standards, increasing implementation of EHR systems, and increasing utilization of CAC solutions to curtail the soaring healthcare costs.
The computer-assisted coding market in this report is segmented on the basis of products and services, application, mode of delivery, end user, and region. Based on products and services, the market is segmented into solutions and services. The CAC services segment is expected to register the highest CAGR during the forecast period. The growing demand for CAC services is resulting from the larger implementation of electronic health record (EHR) systems, rising transition from ICD-9 to ICD-10-CM standards, and the increasing demand for advanced coding systems.
On the basis of mode of delivery, the global computer-assisted coding market is segmented into web-based solutions, cloud-based solutions, and on-premise solutions. The cloud-based solutions segment is expected to grow at the highest CAGR during the forecast period. This is attributed to the benefits of cloud-based solutions which do not require upfront capital investments for hardware and capacity flexibility. This is the major factor responsible for the high growth in this market.

On the basis of application, the market is categorized into three types—automated computer-assisted encoding, management reporting and analytics, and clinical code auditing. The automated computer-assisted encoding segment is expected to grow at the highest rate during the forecast period. Growth in this market is largely driven by the rising need to minimize coding errors, reduce healthcare expenditure, and the mandate to adopt the 10th revision of the ICD-10 standards in the U.S.
Computer Assisted Coding Market


The major end users of computer-assisted coding are healthcare providers and healthcare payers. The providers are further segmented into hospitals, physicians’ practices, clinical laboratories, academic medical centers, and other healthcare institutions. In 2016, the hospitals segment accounted for the largest share of the global computer-assisted coding market, and it is expected to grow at the highest rate during the forecast period. The high growth rate of the hospitals segment can be primarily attributed to the successful and high adoption of computer-assisted coding to curtail healthcare delivery costs while maintaining compliance.

Contact:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Location: Dundee Rd, Illinois, USA

Comments

Post a Comment

Popular posts from this blog

Key Players in the Pyrogen Testing Market Focus on Partnerships, Agreements, & Collaborations, Acquisitions, New Product launches, and Expansions

Image
The report  " Pyrogen Testing Market  by Product (Instruments, Services, Kits and Reagents), Application (Pharmaceutical & Biotechnology, Medical Devices, Other), & by Test (In Vitro, LAL, Gel Clot, Turbidimetric, Chromogenic, Rabbit) - Global Forecasts to 2021 " ,  report provides a detailed overview of the major drivers, restraints, opportunities, current market trends, and strategies impacting the global pyrogen testing market along with the estimates and forecasts of the revenue and market share analysis. Speak to Analyst @  https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=255266155 The global pyrogen testing market is valued at $462.38 million in 2014 and is expected to grow at a CAGR of 12.23%, to reach $823.14 million by 2019. Pyrogen testing is used to determine the bacterial toxins in products intended for medical or veterinary use. Rapidly growing pharmaceutical and biotechnology industries are a major growth driver for this market. Further
Read more

Non Invasive Prenatal Testing Market| Market Trends by Instruments, Consumables, Method, Application and End User

The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period. The non-invasive prenatal testing (NIPT) market is expected to reach USD 2.88 billion by 2021 from USD 1.35 billion in 2016, at a CAGR of 16.4% from 2016 to 2021. The instruments segment is divided into ultrasound device, NGS systems, PCR instruments, microarrays, and other instruments. In 2016, the consumables segment accounted for the largest share of the market. The high growth in this segment is attributed to the repeated requirements of consumables as compared to instruments in NIPT. Based on application
Read more

Global Glycomics Market Players Pursue the Strategies of Product Launches, Agreements, Expansions, Acquisitions, and Collaborations

Image
The major players in this market include Agilent Technologies (U.S.), Bruker Corp. (U.S.), Danaher Corp. (U.S.), New England Biolabs (U.S.), Prozyme Inc. (U.S.), Shimadzu Corp. (Japan), Sigma-Aldrich Corp. (U.S.), Takara Bio (Japan), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S.). The glycomics market is dominated by a few major players, with the top five players accounting for a majority of the market share. The top four players for glycomics enzymes, kits, and reagents have a combined market share of about 75.2% and for glycomics instruments have a combined market share of about 76.0%. The global glycomics market is highly evolved, with multiple different product segments. An analysis of market developments between 2011 and 2014 revealed that new product launches was the most important growth strategy employed by market leaders in this period. This strategy was adopted by most players in this market, except New England Biolabs (U.S.) and Takara Bio, Inc. (Japan).
Read more